In several studies, the prevalence of ASCL1 expression in SCLC has been reported as 54%–73% of SCLC, which makes ASCL1 worthy of investigation as a potential therapeutic and prognostic biomarker.11, 12, 13, 14. This evidence concerns the gene ASCL1 and small cell lung carcinoma.